Year archive

DUOPHARMA BIOTECH BERHAD — 2026 filings

All 42 regulatory filings released by DUOPHARMA BIOTECH BERHAD in 2026, sourced directly from the official regulator.

42 Filings

2026 Period

2026 filings (42)

Filing	Released	Lang
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Major Shareholding Notification	2026-05-21	English
General Meetings: Outcome of Meeting Declaration of Voting Results & Voting Rights Announcements	2026-05-20	English
OTHERSDuopharma Biotech Contributes to National Pharmaceutical Self-Reliance Through Manufacturing Capacity and Portfolio Growth Earnings Release FY 2025	2026-05-20	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Major Shareholding Notification	2026-05-19	English
Quarterly rpt on consolidated results for the financial period ended 31/03/2026 Interim / Quarterly Report Q1 2026	2026-05-13	English
OTHERSDuopharma Biotech sees profit growth in Q1FY2026 alongside insulin supply normalisation Earnings Release Q1 2026	2026-05-13	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - PERMODALAN NASIONAL BERHAD Regulatory Filings	2026-05-03	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - YAYASAN PELABURAN BUMIPUTRA Regulatory Filings	2026-05-03	English
Annual Report & CG Report - 2025 Regulatory Filings	2026-04-20	English
Annual Audited Accounts - 31 Dec 2025 Regulatory Filings	2026-04-20	English
General Meetings: Notice of Meeting Regulatory Filings	2026-04-19	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-30	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-23	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-18	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-09	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-08	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-05	English
MATERIAL LITIGATIONMATERIAL LITIGATION KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY- Regulatory Filings	2026-03-04	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-04	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-03	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - LEMBAGA TABUNG HAJI Regulatory Filings	2026-03-03	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-02	English
Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - LEMBAGA TABUNG HAJI Regulatory Filings	2026-03-02	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-03-01	English
DPHARMA - Notice of Book Closure Regulatory Filings	2026-02-26	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-02-26	English
MATERIAL LITIGATIONMATERIAL LITIGATION KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY- Regulatory Filings	2026-02-25	English
Quarterly rpt on consolidated results for the financial period ended 31/12/2025 Regulatory Filings	2026-02-25	English
Second Interim Dividend Regulatory Filings	2026-02-25	English
OTHERSDuopharma Biotech maintains robust revenue and profit growth momentum Regulatory Filings	2026-02-25	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-02-25	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-02-24	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-02-19	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-02-18	English
OTHERSACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS THE "LETTER OF AWARD" OR "LOA") FOR THE SUPPLY OF RECOMBINANT HUMAN INSULIN FORMULATIONS (HEREINAFTER REFERRED TO AS THE "PRODUCTS") TO THE Regulatory Filings	2026-02-15	English
OTHERSACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS THE "LETTER OF AWARD" OR "LOA") FOR THE SUPPLY OF INSULIN INJECTION (HEREINAFTER REFERRED TO AS THE "PRODUCT") BY DUOPHARMA (M) SENDIRIAN Regulatory Filings	2026-02-15	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-02-12	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-02-10	English
MATERIAL LITIGATIONKUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF Regulatory Filings	2026-02-04	English
MATERIAL LITIGATIONKUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF Regulatory Filings	2026-02-02	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-02-02	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD Regulatory Filings	2026-01-28	English